Skip to main content

30-10-2017 | Melanoma | Article

PET and SPECT imaging of melanoma: the state of the art

European Journal of Nuclear Medicine and Molecular Imaging

Authors: Weijun Wei, Emily B. Ehlerding, Xiaoli Lan, Quanyong Luo, Weibo Cai

Publisher: Springer Berlin Heidelberg


Melanoma represents the most aggressive form of skin cancer, and its incidence continues to rise worldwide. 18F–FDG PET imaging has transformed diagnostic nuclear medicine and has become an essential component in the management of melanoma, but still has its drawbacks. With the rapid growth in the field of nuclear medicine and molecular imaging, a variety of promising probes that enable early diagnosis and detection of melanoma have been developed. The substantial preclinical success of melanin- and peptide-based probes has recently resulted in the translation of several radiotracers to clinical settings for noninvasive imaging and treatment of melanoma in humans. In this review, we focus on the latest developments in radiolabeled molecular imaging probes for melanoma in preclinical and clinical settings, and discuss the challenges and opportunities for future development.

Please log in to get access to this content

Related topics